The London Joint Working Group on Substance Use and Hepatitis C (LJWG) was formed in 2009 to help drive improvements in the prevention, diagnosis and treatment of hepatitis C in people who use drugs in London. Service provision was identified as disjointed and patchy, and action needed to be taken to avert a major public health crisis.
With a common aim of improving outcomes for people with hepatitis C in this vulnerable population, the LJWG collaborates with stakeholders from the health service, providers, policy makers, pharmaceutical companies and service users.
The LJWG published a consensus of recommendations in October 2011 that emphasized the need for education and training, and the need for integration and collaboration across drug and specialist hepatitis treatment services, public health, prisons and primary care.
Since the publication of The London Consensus, the LJWG continues to support the community to help implement the recommendations and provide evidence for improvement in service provision.